Your browser doesn't support javascript.
loading
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19.
Hoffmann, Markus; Schroeder, Simon; Kleine-Weber, Hannah; Müller, Marcel A; Drosten, Christian; Pöhlmann, Stefan.
Afiliação
  • Hoffmann M; Deutsches Primatenzentrum-Leibniz Institute for Primate Research, Göttingen, Germany.
  • Schroeder S; Faculty of Biology and Psychology, University Göttingen, Göttingen, Germany.
  • Kleine-Weber H; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Berlin, Germany.
  • Müller MA; German Centre for Infection Research, associated partner Charité, Berlin, Germany.
  • Drosten C; Deutsches Primatenzentrum-Leibniz Institute for Primate Research, Göttingen, Germany.
  • Pöhlmann S; Faculty of Biology and Psychology, University Göttingen, Göttingen, Germany.
Antimicrob Agents Chemother ; 64(6)2020 05 21.
Article em En | MEDLINE | ID: mdl-32312781
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coronavírus Relacionado à Síndrome Respiratória Aguda Grave Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coronavírus Relacionado à Síndrome Respiratória Aguda Grave Idioma: En Ano de publicação: 2020 Tipo de documento: Article